Literature DB >> 33186264

Cerebral Venous Sinus Thrombosis in the COVID-19 Pandemic.

Chaitanya B Medicherla1, Rachel A Pauley, Adam de Havenon, Shadi Yaghi, Koto Ishida, Jose L Torres.   

Abstract

BACKGROUND: Recent studies have noted concern for increased thromboembolic events in the setting of Coronavirus Disease 2019 (COVID-19). Cerebral venous sinus thrombosis (CVST) is a form of thromboembolism that has been observed as a neuro-ophthalmologic complication of COVID-19.
METHODS: Review of the scientific literature.
RESULTS: In this article, we report an overview of CVST epidemiology, clinical presentation, diagnostics, disease pathophysiology, and management in the setting of COVID-19.
CONCLUSION: CVST is an uncommon thromboembolic event with variable phenotypes and multiple etiologies. Neurologic complications can be severe, including significant visual deficits and death. Current observations suggest that the risk of CVST may be profoundly impacted by this novel COVID-19 pandemic, thus prompting increased attention to disease presentation, pathogenesis, and management.

Entities:  

Year:  2020        PMID: 33186264     DOI: 10.1097/WNO.0000000000001122

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  16 in total

1.  SARS-CoV-2 vaccination associated venous sinus thrombosis in three patients.

Authors:  Josef Finsterer
Journal:  J Appl Biomed       Date:  2022-07-26       Impact factor: 0.500

2.  Pattern of molecular mimicry between spike protein of SARS CoV2 and human thrombopoietin in beta, delta and omicron variants: a basic pathophysiological process of COVID-19 related thrombocytopenia.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  Am J Blood Res       Date:  2022-04-15

3.  Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units.

Authors:  Ari Ercole; Denise Battaglini; Andrea Lavinio; Sandra Magnoni; Rafael Badenes; Fabio Silvio Taccone; Raimund Helbok; William Thomas; Paolo Pelosi; Chiara Robba
Journal:  Crit Care       Date:  2021-04-22       Impact factor: 9.097

Review 4.  COVID-19, neurovascular thrombotic problem and short summary on blood coagulation disorder: a brief review.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2022-01-10

5.  Intracranial otogenic complications in adults: new factors that influenced its onset, frequency and nature.

Authors:  Małgorzata Wierzbicka; Michalina Staśkiewicz; Oskar Rosiak; Katarzyna Karmelita-Katulska; Witold Szyfter; Wojciech Gawęcki
Journal:  J Otolaryngol Head Neck Surg       Date:  2022-03-04

6.  Case report of a fulminant non-aneurysmal convexity subarachnoid hemorrhage after COVID-19.

Authors:  Maximilian Scheer; Anja Harder; Sabine Wagner; Richard Ibe; Julian Prell; Christian Scheller; Christian Strauss; Sebastian Simmermacher
Journal:  Interdiscip Neurosurg       Date:  2021-11-29

Review 7.  Stroke Treatment in the Era of COVID-19: a Review.

Authors:  Marialaura Simonetto; Paul M Wechsler; Alexander E Merkler
Journal:  Curr Treat Options Neurol       Date:  2022-04-25       Impact factor: 3.972

Review 8.  Neuro-Ophthalmologic Manifestations of Novel Coronavirus.

Authors:  Devin Betsch; Paul R Freund
Journal:  Adv Ophthalmol Optom       Date:  2021-04-28

Review 9.  Post-SARS-CoV-2 vaccination venous sinus thrombosis: a literature review of 308 cases.

Authors:  Josef Finsterer; Sinda Zarrouk
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2021-12-20

Review 10.  COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era.

Authors:  Ender Volkan
Journal:  Mol Biotechnol       Date:  2021-06-18       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.